Browse > Article
http://dx.doi.org/10.5999/aps.2021.00185

The management of breast implant-associated anaplastic large cell lymphoma in the setting of pregnancy: seeking for clinical practice guidelines  

Elia, Rossella (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro)
Maruccia, Michele (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro)
De Pascale, Aurelia (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro)
Di Napoli, Arianna (Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome)
Ingravallo, Giuseppe (Section of Pathology, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro)
Giudice, Giuseppe (Division of Plastic and Reconstructive Surgery, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro)
Publication Information
Archives of Plastic Surgery / v.48, no.4, 2021 , pp. 373-377 More about this Journal
Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently described form of T-cell non-Hodgkin lymphoma now formally recognized by the World Health Organization classification of lymphoid neoplasms. The aim of this paper is to report the first case of BIA-ALCL diagnosed in a pregnant patient. It is well known that BIA-ALCL appears as an indolent lymphoma with a good prognosis when diag-nosed at early stages and clinical guidelines for its management have been clearly published. Nevertheless, they lack a standardized approach for BIA-ALCL during pregnancy. With limited experience in our case, treatment has been safely postponed after term without affecting patient's overall prognosis and without fetal complication. The fact that the disease was diagnosed at an early stage (stage I) undoubtedly influenced the course of treatment. A multidisciplinary approach weighing the risks and benefits of treatment is of paramount importance in order to ensure the best possible outcome for both the mother and her child and clinical update guidelines should be issued.
Keywords
Lymphoma, large-cell, anaplastic; Lymphoma; Pregnancy; Breast implants; World Health Organization;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Di Napoli A, De Cecco L, Piccaluga PP, et al. Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas. Mod Pathol 2019;32:216-30.   DOI
2 Kato M, Ichimura K, Hayami Y, et al. Pregnancy-associated cytotoxic lymphoma: a report of 4 cases. Int J Hematol 2001; 74:186-92.   DOI
3 Giudice G, Maruccia M, Vestita M, et al. The medial-central septum based mammaplasty: a reliable technique to preserve nippleareola complex sensitivity in post bariatric patients. Breast J 2019;25:590-6.   DOI
4 Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 2019;39(Suppl_1):S3-13.   DOI
5 Lyapichev KA, Pina-Oviedo S, Medeiros LJ, et al. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol 2020;33:367-79.   DOI
6 Lesesve JF, Buisine J, Gregoire MJ, et al. Leukaemic small cell variant anaplastic large cell lym-phoma during pregnancy. Clin Lab Haematol 2000;22:297-301.   DOI
7 Iyengar P, Reid-Nicholson M, Moreira AL. Pregnancy-associated anaplastic large-cell lymphoma of the breast: a rare mimic of ductal carcinoma. Diagn Cytopathol 2006;34:298-302.   DOI
8 Alalade AO, Odejinmi FO. A rare and potentially fatal cause of pelvic pain in pregnancy: anaplastic large cell lymphoma. J Obstet Gynaecol 2006;26:691-2.   DOI
9 Peccatori FA, Azim HA Jr, Pruneri G, et al. Management of anaplastic large-cell lymphoma during pregnancy. J Clin Oncol 2009;27:e75-7.   DOI
10 Orecchia R, Lucignani G, Tosi G. Prenatal irradiation and pregnancy: the effects of diagnostic imaging and radiation therapy. Recent Results Cancer Res 2008;178:3-20.   DOI
11 Maruccia M, Elia R, Gurrado A, et al. Skin-reducing mastectomy and pre-pectoral breast reconstruction in large ptotic breasts. Aesthetic Plast Surg 2020;44:664-72.   DOI
12 Di Napoli A, Jain P, Duranti E, et al. Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol 2018; 180:741-4.   DOI
13 Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375-90.   DOI
14 Campanale A, Spagnoli A, Lispi L, et al. The crucial role of surgical treatment in BIA-ALCL prognosis in early- and advanced-stage patients. Plast Reconstr Surg 2020;146:530e-538e.   DOI
15 Clemens MW, Brody GS, Mahabir RC, et al. How to diagnose and treat breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 2018;141:586e-599e.   DOI
16 Zagouri F, Dimitrakakis C, Marinopoulos S, et al. Cancer in pregnancy: disentangling treatment modalities. ESMO Open 2016;1:e000016.   DOI
17 Clemens MW, Medeiros LJ, Butler CE, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol 2016;34:160-8.
18 Kisacik B, Akdogan A, Maras Y, et al. Anaplastic large cell lymphoma presenting with symmetric polyarthritis in pregnancy. Rheumatol Int 2008;28:909-11.   DOI
19 Bucaria V, Elia R, Maruccia M, et al. Methylene blue: a color test for a quality de-epithelialization. Aesthetic Plast Surg 2018;42:1434-5.   DOI
20 Santanelli di Pompeo F, Laporta R, Sorotos M, et al. Breast implant-associated anaplastic large cell lymphoma: proposal for a monitoring protocol. Plast Reconstr Surg 2015;136: 144e-151e.   DOI